These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 18364570)

  • 1. Monoclonal antibodies target intracellular PRL phosphatases to inhibit cancer metastases in mice.
    Guo K; Tang JP; Tan CP; Wang H; Zeng Q
    Cancer Biol Ther; 2008 May; 7(5):750-7. PubMed ID: 18364570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of PRL-3- and PRL-1-specific monoclonal antibodies as potential diagnostic markers for cancer metastases.
    Li J; Guo K; Koh VW; Tang JP; Gan BQ; Shi H; Li HX; Zeng Q
    Clin Cancer Res; 2005 Mar; 11(6):2195-204. PubMed ID: 15788667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PRL phosphatases as potential molecular targets in cancer.
    Stephens BJ; Han H; Gokhale V; Von Hoff DD
    Mol Cancer Ther; 2005 Nov; 4(11):1653-61. PubMed ID: 16275986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphatase of regenerating liver: a novel target for cancer therapy.
    Campbell AM; Zhang ZY
    Expert Opin Ther Targets; 2014 May; 18(5):555-69. PubMed ID: 24579927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the human phosphatases of regenerating liver (PRLs) in colonic adenocarcinoma and its correlation with lymph node metastasis.
    Wang Y; Li ZF; He J; Li YL; Zhu GB; Zhang LH; Li YL
    Int J Colorectal Dis; 2007 Oct; 22(10):1179-84. PubMed ID: 17440740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting PRL phosphatases in hematological malignancies.
    Xiao S; Chen H; Bai Y; Zhang ZY; Liu Y
    Expert Opin Ther Targets; 2024 Apr; 28(4):259-271. PubMed ID: 38653737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenylation-dependent association of protein-tyrosine phosphatases PRL-1, -2, and -3 with the plasma membrane and the early endosome.
    Zeng Q; Si X; Horstmann H; Xu Y; Hong W; Pallen CJ
    J Biol Chem; 2000 Jul; 275(28):21444-52. PubMed ID: 10747914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting phosphatases of regenerating liver (PRLs) in cancer.
    Wei M; Korotkov KV; Blackburn JS
    Pharmacol Ther; 2018 Oct; 190():128-138. PubMed ID: 29859177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility.
    Fiordalisi JJ; Keller PJ; Cox AD
    Cancer Res; 2006 Mar; 66(6):3153-61. PubMed ID: 16540666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PRL-3 initiates tumor angiogenesis by recruiting endothelial cells in vitro and in vivo.
    Guo K; Li J; Wang H; Osato M; Tang JP; Quah SY; Gan BQ; Zeng Q
    Cancer Res; 2006 Oct; 66(19):9625-35. PubMed ID: 17018620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms of the PRL phosphatases.
    Rios P; Li X; Köhn M
    FEBS J; 2013 Jan; 280(2):505-24. PubMed ID: 22413991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catalytic domain of PRL-3 plays an essential role in tumor metastasis: formation of PRL-3 tumors inside the blood vessels.
    Guo K; Li J; Tang JP; Koh V; Gan BQ; Zeng Q
    Cancer Biol Ther; 2004 Oct; 3(10):945-51. PubMed ID: 15326366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphatase of regenerating liver-3 localizes to cyto-membrane and is required for B16F1 melanoma cell metastasis in vitro and in vivo.
    Song R; Qian F; Li YP; Sheng X; Cao SX; Xu Q
    PLoS One; 2009; 4(2):e4450. PubMed ID: 19214221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An anticancer effect of curcumin mediated by down-regulating phosphatase of regenerating liver-3 expression on highly metastatic melanoma cells.
    Wang L; Shen Y; Song R; Sun Y; Xu J; Xu Q
    Mol Pharmacol; 2009 Dec; 76(6):1238-45. PubMed ID: 19779032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PRL-3 expression in metastatic cancers.
    Bardelli A; Saha S; Sager JA; Romans KE; Xin B; Markowitz SD; Lengauer C; Velculescu VE; Kinzler KW; Vogelstein B
    Clin Cancer Res; 2003 Nov; 9(15):5607-15. PubMed ID: 14654542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphatase of regenerating liver-1 promotes cell migration and invasion and regulates filamentous actin dynamics.
    Nakashima M; Lazo JS
    J Pharmacol Exp Ther; 2010 Aug; 334(2):627-33. PubMed ID: 20484558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PRL-3 and PRL-1 promote cell migration, invasion, and metastasis.
    Zeng Q; Dong JM; Guo K; Li J; Tan HX; Koh V; Pallen CJ; Manser E; Hong W
    Cancer Res; 2003 Jun; 63(11):2716-22. PubMed ID: 12782572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1H, 15N, 13C resonance assignments of the reduced and active form of human Protein Tyrosine Phosphatase, PRL-1.
    Skinner AL; Laurence JS
    Biomol NMR Assign; 2009 Jun; 3(1):61-5. PubMed ID: 19636948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PRL-3 phosphatase is implicated in ovarian cancer growth.
    Polato F; Codegoni A; Fruscio R; Perego P; Mangioni C; Saha S; Bardelli A; Broggini M
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6835-9. PubMed ID: 16203771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Anticancer Agents Based on Targeting the Trimer Interface of the PRL Phosphatase.
    Bai Y; Yu ZH; Liu S; Zhang L; Zhang RY; Zeng LF; Zhang S; Zhang ZY
    Cancer Res; 2016 Aug; 76(16):4805-15. PubMed ID: 27325652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.